← Back to Clinical Trials
Recruiting NCT07289191

NCT07289191 Development of a Novel Strategy to Analyze the Effect on Gait Using Transcutaneous Spinal Current Stimulation in Incomplete Spinal Cord Injured Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07289191
Status Recruiting
Phase
Sponsor Institut Guttmann
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2021-01-01
Primary Completion 2024-09-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
transcutaneous spinal cord stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2021-01-01 with a primary completion date of 2024-09-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To determine whether the combination of non-invasive spinal cord stimulation together with gait rehabilitation reduces spasticity and facilitates recovery of lower limb motor strength and gait function in patients with incomplete SCI, as well as studying the underlying physiopathological changes following incomplete SCI and its modulation by non-invasive stimulation techniques.

Eligibility Criteria

Inclusion Criteria: * Male or female more than 18 years old; * With a stable traumatic o nor traumatic incomplete motor cervical or thoracic SCI; * Time since SCI more than 6 months; * American Spinal Injury Association Impairment Scale (AIS)-D who could realize gait at least 6 meters with or without technical help; * Capacity for compression the nature of the study and signed informed consent. Exclusion Criteria: * Unstable medical condition (cancer, acute infections, etc.); * Severe spasticity (≥ 3 score on the Modified Ashworth scale (MAS)), * Peripheral nerve affectation; * Ulcers on the electrode applied area; * Intolerance of tSCS.

Frequently Asked Questions

Who can join the NCT07289191 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07289191 currently recruiting?

Yes, NCT07289191 is actively recruiting participants. Visit ClinicalTrials.gov or contact Institut Guttmann to inquire about joining.

Where is the NCT07289191 trial being conducted?

This trial is being conducted at Badalona, Spain.

Who is sponsoring the NCT07289191 clinical trial?

NCT07289191 is sponsored by Institut Guttmann. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology